ALBIREO PHARMA, INC. (32)

Browse by Contract Category

Contracts

Purchase and Sale Agreement, dated as of September 22, 2022, by and among the Registrant, Albireo AB and Sagard Healthcare Partners (Delaware) LP (Filed With SEC on November 8, 2022)
Nonemployee Director Compensation Policy, as amended (Filed With SEC on August 10, 2022)
Sublease Agreement, dated as of December 7, 2021, by and between the Registrant Institute For Healthcare Improvement (Filed With SEC on March 1, 2022)
Description of the Registrants Securities (Filed With SEC on March 1, 2022)
Sales Agreement, dated February 25, 2021, by and between Albireo Pharma, Inc. and Cowen and Company, LLC (Filed With SEC on February 25, 2021)
Sublease Agreement, dated as of December 6, 2021, by and between the Registrant and Hi Marley, Inc (Filed With SEC on March 1, 2022)
Amendment No. 3 to Office Lease Agreement, dated as of June 30, 2021, by and between NS Boston III PO Owner LLC and the Registrant (Filed With SEC on March 1, 2022)
Albireo Pharma, Inc. Incentive Compensation Recoupment Policy (Filed With SEC on November 4, 2021)
Asset Purchase Agreement, dated as of August 31, 2021, by and among the Registrant, Albireo AB and Ares Trading SA (Filed With SEC on November 4, 2021)
Albireo Pharma, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on June 21, 2021)
Nonemployee Director Compensation Policy (Filed With SEC on May 6, 2021)
Form of Restricted Stock Unit Agreement under the Albireo Pharma, Inc. 2020 Inducement Equity Incentive Plan (Filed With SEC on November 5, 2020)
Form of Stock Option Agreement under the Albireo Pharma, Inc. 2020 Inducement Equity Incentive Plan (Filed With SEC on November 5, 2020)
Albireo Pharma, Inc. 2020 Inducement Equity Incentive Plan (Filed With SEC on November 5, 2020)
Underwriting Agreement, dated September 9, 2020, by and among the Company, Cowen and Company, LLC and William Blair & Company, L.L.C (Filed With SEC on September 10, 2020)
Amendment No 1. to Royalty Interest Acquisition Agreement, dated as of June 8, 2020, by and among Elobix AB, HealthCare Royalty Partners III, L.P. and, solely for the purposes... (Filed With SEC on June 9, 2020)
Form of Warrant issued by the Company to Hercules Capital, Inc (Filed With SEC on June 9, 2020)
Loan and Security Agreement, dated as of June 8, 2020, by and between the Company and Hercules Capital, Inc (Filed With SEC on June 9, 2020)
Second amendment to Lease dated as of May 4, 2020, by and between NS Boston III PO Owner LLC and the Registrant (Filed With SEC on May 7, 2020)
Nonemployee Director Compensation Policy (Filed With SEC on May 7, 2020)
Description of the Registrants Securities (Filed With SEC on March 2, 2020)
Underwriting Agreement, dated January 29, 2020, by and between the Company and Jefferies LLC (Filed With SEC on January 30, 2020)
Employment Agreement dated as of October 31, 2019 by and between the Registrant and Michelle Graham (Filed With SEC on November 6, 2019)
Albireo Pharma, Inc. 2018 Equity Incentive Plan, as amended (Filed With SEC on June 18, 2019)
Non-Employee Director Compensation Policy (Filed With SEC on May 9, 2019)
Employment Agreement dated as of March 25, 2019 by and between the Registrant and Pamela Stephenson (Filed With SEC on May 9, 2019)
Amendment No. 1 to Office Lease Agreement dated as of March 28, 2019, by and between Albireo Pharma, Inc. and POSIG Investors, LLC (Filed With SEC on April 3, 2019)
Amended and Restated Employment Agreement, dated as of March 6, 2019, by and between Albireo, AB and Jan P. Mattsson, Ph.D (Filed With SEC on March 6, 2019)
Amended and Restated Employment Agreement, dated as of March 6, 2019, by and between Albireo, Inc. and Jason G. Duncan (Filed With SEC on March 6, 2019)
Amended and Restated Employment Agreement, dated as of March 6, 2019, by and between the Registrant and Patrick Horn (Filed With SEC on March 6, 2019)
Amended and Restated Employment Agreement, dated as of March 6, 2019, by and between the Registrant and Martha J. Carter (Filed With SEC on March 6, 2019)
Amended and Restated Employment Agreement, dated as of March 6, 2019, by and between the Registrant and Ronald H.W. Cooper (Filed With SEC on March 6, 2019)